Effect of Intensity-Modulated Pelvic Radiotherapy on Second Cancer Risk in the Postoperative Treatment of Endometrial and Cervical Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 539-545

  Zwahlen, Daniel R ^a,b   Ruben, Jeremy D ^a   Jones, Phillip ^a   Gagliardi, Frank ^a   Millar, Jeremy L ^a   Schneider, Uwe ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Cervical cancer; Comparative treatment planning; Endometrial cancer; Intensity modulated radiotherapy; Second cancers

Indexed keywords

CERVICAL CANCER; COMPARATIVE TREATMENT PLANNING; ENDOMETRIAL CANCER; INTENSITY-MODULATED RADIOTHERAPY; SECOND CANCERS;

COMPUTERIZED TOMOGRAPHY; RADIOTHERAPY; RISK PERCEPTION; SKIN; THREE DIMENSIONAL;

PHYSICAL THERAPY;

AGED; ARTICLE; CANCER RISK; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; DOSE RESPONSE; ENDOMETRIUM CANCER; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; RADIATION PROTECTION; SECOND CANCER; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; UTERINE CERVIX CANCER;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; OVARIECTOMY; PELVIS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SKIN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 65149106612     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.051     Document Type: Article

References (38)

1. Rotman M., Sedlis A., Piedmonte M.R., et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65 (2006) 169-176
2. Scholten A.N., van Putten W.L., Beerman H., et al. Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63 (2005) 834-838
3. Creutzberg C.L., van Putten W.L., Koper P.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 51 (2001) 1246-1255
4. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
5. Small Jr. W., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 428-434
6. Carballo N., Gonzalez-Cortijo L., Gonzalez-Martin A., et al. Indications for adjuvant radiotherapy treatment after surgery and novel modalities for treatment. Gynecol Oncol 110 (2008) S41-S44
7. D'Souza W.D., Ahamad A.A., Iyer R.B., et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1062-1070
8. Chaturvedi A.K., Engels E.A., Gilbert E.S., et al. Second cancers among 104,760 survivors of cervical cancer: Evaluation of long-term risk. J Natl Cancer Inst 99 (2007) 1634-1643
9. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
10. Kry S.F., Salehpour M., Followill D.S., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-1203
11. Lillicrap S.C., Morgan H.M., and Shakeshaft J.T. X-ray leakage during radiotherapy. Br J Radiol 73 (2000) 793-794
12. Aoyama H., Westerly D.C., Mackie T.R., et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 64 (2006) 962-967
13. Howell R.M., Hertel N.E., Wang Z., et al. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 33 (2006) 360-368
14. Stovall M., Blackwell C.R., Cundiff J., et al. Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 22 (1995) 63-82
15. d'Errico F., Luszik-Bhadra M., Nath R., et al. Depth dose-equivalent and effective energies of photoneutrons generated by 6-18 MV X-ray beams for radiotherapy. Health Phys 80 (2001) 4-11
16. ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 37 (2007) 1-332
17. Schneider U., Zwahlen D., Ross D., et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61 (2005) 1510-1515
18. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
19. Sachs R.K., and Brenner D.J. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A 102 (2005) 13040-13045
20. Dasu A., Toma-Dasu I., Olofsson J., et al. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 44 (2005) 339-347
21. Davis R.H. Production and killing of second cancer precursor cells in radiation therapy: in regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88). Int J Radiat Oncol Biol Phys 59 (2004) 916
22. Schneider U., and Walsh L. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat Environ Biophys 47 (2008) 253-263
23. Xu X.G., Bednarz B., and Paganetti H. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 53 (2008) R193-R241
24. Pirzkall A., Carol M.P., Pickett B., et al. The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys 53 (2002) 434-442
25. Boice Jr. J.D., Day N.E., Andersen A., et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74 (1985) 955-975
26. Kry S.F., Salehpour M., Followill D.S., et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1204-1216
27. Brenner D.J., Curtis R.E., Hall E.J., et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
28. Travis L.B., Fossa S.D., Schonfeld S.J., et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
29. Ruben J.D., Davis S., Evans C., et al. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 70 (2008) 1530-1536
30. Schneider U. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry, et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203). Int J Radiat Oncol Biol Phys 2006;64:1290; author reply 1290-1291.
31. Schneider U., Lomax A., Pemler P., et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 182 (2006) 647-652
32. Nguyen F., Rubino C., Guerin S., et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: Correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70 (2008) 908-915
33. Schneider U., and Kaser-Hotz B. Radiation risk estimates after radiotherapy: Application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys 44 (2005) 235-239
34. Dorr W., and Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 178 (2002) 357-362
35. Followill D., Geis P., and Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 38 (1997) 667-672
36. Howell R.M., Ferenci M.S., Hertel N.E., et al. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery. Med Phys 32 (2005) 786-793
37. de Boer S.F., Kumek Y., Jaggernauth W., et al. The effect of beam energy on the quality of IMRT plans for prostate conformal radiotherapy. Technol Cancer Res Treat 6 (2007) 139-146
38. Palm A., and Johansson K.A. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncol 46 (2007) 462-473